News on DISHMAN Europe Ltd from BioPortfolio.com http://www.BioPortfolio.com Consolidated DISHMAN Europe Ltd news from BioPortfolio.com Wed, 10 Feb 2010 08:23:28 GMT en Pharma can count on better US sales, but costs still a worryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038143&HITNO=0&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038143&THISHREF=http://c.moreover.com/click/here.pl%3fz2537498547%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038143&HITNO=0&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038143&THISHREF=http://c.moreover.com/click/here.pl%3fz2537498547%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEconomictimes: Pharma can count on better US sales, but costs still a worryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038142&HITNO=1&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038142&THISHREF=http://c.moreover.com/click/here.pl%3fz2537498228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038142&HITNO=1&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038142&THISHREF=http://c.moreover.com/click/here.pl%3fz2537498228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEconomictimes: Carbogen Amcis opens large-scale high-potency API planthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028091&HITNO=2&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028091&THISHREF=http://c.moreover.com/click/here.pl%3fz2532574961%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028091&HITNO=2&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028091&THISHREF=http://c.moreover.com/click/here.pl%3fz2532574961%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmafocus: Dishman Pharma plant receives US FDA approvalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020479&HITNO=3&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020479&THISHREF=http://c.moreover.com/click/here.pl%3fz2526794156%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020479&HITNO=3&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020479&THISHREF=http://c.moreover.com/click/here.pl%3fz2526794156%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMoneycontrol.com: Dishman pharma's Naroda facility gets USFDA nodhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023864&HITNO=4&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023864&THISHREF=http://c.moreover.com/click/here.pl%3fz2528440503%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023864&HITNO=4&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023864&THISHREF=http://c.moreover.com/click/here.pl%3fz2528440503%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Standard India: Dishman Pharma`s EOU facility at Ahmedabad gets USFDA`s nodhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019314&HITNO=5&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019314&THISHREF=http://c.moreover.com/click/here.pl%3fz2526221304%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019314&HITNO=5&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019314&THISHREF=http://c.moreover.com/click/here.pl%3fz2526221304%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMyIris: Consolidated revenues to grow 20% next year: Dishman Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020062&HITNO=6&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020062&THISHREF=http://c.moreover.com/click/here.pl%3fz2526578724%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020062&HITNO=6&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020062&THISHREF=http://c.moreover.com/click/here.pl%3fz2526578724%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMoneycontrol.com: Drug formulations pep up sector, but contract research spoils Q3 party [The Economic Times, India]http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009046&HITNO=7&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009046&THISHREF=http://c.moreover.com/click/here.pl%3fz2521808456%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009046&HITNO=7&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009046&THISHREF=http://c.moreover.com/click/here.pl%3fz2521808456%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Dishman Pharma Expects New Plant to Generate $200 Million in Saleshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001766&HITNO=8&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001766&THISHREF=http://c.moreover.com/click/here.pl%3fz2518557076%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001766&HITNO=8&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001766&THISHREF=http://c.moreover.com/click/here.pl%3fz2518557076%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFDA News: Dishman pharma begins API facility in Ahmedabad, Indiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990536&HITNO=9&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990536&THISHREF=http://c.moreover.com/click/here.pl%3fz2513350357%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990536&HITNO=9&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990536&THISHREF=http://c.moreover.com/click/here.pl%3fz2513350357%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNew Statesman: Dishman net under pressure at Rs 33 cr in Q3http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989935&HITNO=10&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989935&THISHREF=http://c.moreover.com/click/here.pl%3fz2513020404%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989935&HITNO=10&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989935&THISHREF=http://c.moreover.com/click/here.pl%3fz2513020404%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Dishman Pharma opens API facility in Indiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990129&HITNO=11&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990129&THISHREF=http://c.moreover.com/click/here.pl%3fz2513136491%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990129&HITNO=11&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990129&THISHREF=http://c.moreover.com/click/here.pl%3fz2513136491%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: `Reduce` Dishman Pharma; target Rs 208: Emkayhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981129&HITNO=12&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981129&THISHREF=http://c.moreover.com/click/here.pl%3fz2506796371%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981129&HITNO=12&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981129&THISHREF=http://c.moreover.com/click/here.pl%3fz2506796371%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMyIris: Dishman Pharma Consolidated 3Q Net Profit INR330.8 Million Vs INR395.7 Millionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976297&HITNO=13&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976297&THISHREF=http://c.moreover.com/click/here.pl%3fz2504338146%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976297&HITNO=13&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976297&THISHREF=http://c.moreover.com/click/here.pl%3fz2504338146%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNasdaq: Dishman Pharma Consolidated 3Q Net Profit INR330.8 Million Vs INR395.7 Millionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976064&HITNO=14&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976064&THISHREF=http://c.moreover.com/click/here.pl%3fz2504248887%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976064&HITNO=14&MSIZE=40&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DISHMAN%20Europe%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976064&THISHREF=http://c.moreover.com/click/here.pl%3fz2504248887%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: